nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.09.2007 | Editorial commentary

Regional CBF changes in Parkinson’s disease: the importance of functional neuroimaging analyses

verfasst von: Bárbara J. Amorim, Erica C. S. Camargo, Elba C. S. C. Etchebehere

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 9/2007

Einloggen, um Zugang zu erhalten

Excerpt

Parkinson’s disease (PD) affects approximately 1% of the population over the age of 65 years. The basic clinical findings include bradykinesia, cogwheel rigidity, resting tremor and postural instability. However, the diagnosis of PD may be difficult, and it has been estimated that only 53% of patients using antiparkinsonian medication actually present with PD [1]. Thus, researchers are striving to discover the best strategies to help clinicians improve the diagnostic accuracy. Genetic and olfactory tests, magnetic resonance imaging (MRI) and dopamine transporter single-photon emission computed tomography (SPECT) images have been used in the differential diagnosis of PD. …

Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson’s disease. Lancet Neurol 2006;5:75–86.PubMedCrossRef

Hsu JL, Jung TP, Hsu CY, Hsu WC, Chen YK, Duann JR, et al. Regional CBF changes in Parkinson’s disease: a correlation with motor dysfunction. Eur J Nucl Med Mol Imaging 2007; DOI 10.1007/s00259-006-0360-7.

Sawada H, Udaka F, Kameyama M, Seriu N, Nishinaka K, Shindou K, et al. SPECT findings in Parkinson’s disease associated with dementia. J Neurol Neurosurg Psychiatry 1992;55:960–3.PubMed

Matsui H, Udaka F, Miyoshi T, Hara N, Tamura A, Oda M, et al. N-isopropyl-p-¹²³I iodoamphetamine single photon emission computed tomography study of Parkinson’s disease with dementia. Intern Med 2005;44:1046–50.PubMedCrossRef

Liu RS, Lin KN, Wang SJ, Shan DE, Fuh JL, Yeh SH, et al. Cognition and⁹⁹Tc^m-HMPAO SPECT in Parkinson’s disease. Nucl Med Commun 1992;13:744–8.PubMedCrossRef

Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G. Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson’s disease. Neurol Sci 2001;22:45–6.PubMedCrossRef

Derejko M, Slawek J, Wieczorek D, Brochhuis B, Dubaniewicz M, Lass P. Regional cerebral blood flow in Parkinson’s disease as an indicator of cognitive impairment. Nucl Med Commun 2006;27:945–51.PubMedCrossRef

Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O’Brien JT. Regional cerebral blood flow in Parkinson’s disease with and without dementia. Neuroimage 2003;20:1309–19.PubMedCrossRef

Mito Y, Yoshida K, Yabe I, Makino K, Hirotani M, Tashiro K, et al. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson’s disease with and without dementia, and Alzheimer’s disease. Clin Neurol Neurosurg 2005;107:396–403.PubMedCrossRef

10.

Feigin A, Antonini A, Fukada M, De Notaris R, Benti R, Pezzoli G, et al. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Mov Disord 2002;17:1265–70.PubMedCrossRef

11.

Bosman T, Van Laere K, Santens P. Anatomically standardised^99mTc-ECD brain perfusion SPECT allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson’s disease. Eur J Nucl Med Mol Imaging 2003;30:16–24.PubMedCrossRef

12.

Markus HS, Costa DC, Lees AJ. HMPAO SPECT in Parkinson’s disease before and after levodopa: correlation with dopaminergic responsiveness. J Neurol Neurosurg Psychiatry 1994;57:180–5.PubMedCrossRef

13.

Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N. SPECT image analysis using statistical parametric mapping in patients with Parkinson’s disease. J Nucl Med 1999;40:1583–9.PubMed

Titel: Regional CBF changes in Parkinson’s disease: the importance of functional neuroimaging analyses
verfasst von: Bárbara J. Amorim
Erica C. S. Camargo
Elba C. S. C. Etchebehere
Publikationsdatum: 01.09.2007
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 9/2007
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-007-0411-8

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2007

Regional CBF changes in Parkinson’s disease: a correlation with motor dysfunction

Accuracy of 3D acquisition mode for myocardial FDG PET studies using a BGO-based scanner

Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer’s disease

A gradient-based method for segmenting FDG-PET images: methodology and validation

Guidelines for lung scintigraphy in children

Thyroid scintigraphy and perchlorate test after recombinant human TSH: a new tool for the differential diagnosis of congenital hypothyroidism during infancy